Wegovy Savings Card: Who Qualifies in 2026

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

The list price for Wegovy injection and pill is about $1,350 per month [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV].
Without insurance, the Wegovy injection pen can cost $199-$349 per month through NovoNordisk’s NovoCare Pharmacy [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV].
The Wegovy pill, approved in late 2025, may cost $149-$299 monthly without insurance [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV].
Wegovy may cause serious side effects, including possible thyroid tumors [https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html].

Navigating the cost of GLP-1 medications like Wegovy in 2026 involves understanding various pricing structures, insurance coverage, and manufacturer savings programs. While Wegovy has a list price of about $1,350 per month for both the weekly injection pen and the daily pill, the actual amount people pay can differ greatly depending on their individual circumstances [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV]. For those without insurance, cash-pay prices for the injection pen typically range from $199 to $349 per month, while the newly approved Wegovy pill might cost $149 to $299 monthly through NovoNordisk's NovoCare Pharmacy [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV]. Savings cards and coupons can help reduce these costs, potentially saving up to $55 per fill off the retail price [https://www.medicalnewstoday.com/articles/drugs-wegovy-cost]. It is crucial for individuals to stay informed about these shifting prices and programs to make the best decision for their budget and health.

What is the List Price of Wegovy in 2026?

The list price of Wegovy in 2026 is approximately $1,350 per month, applying to both the weekly injection pen and the daily pill formulation. This figure represents the manufacturer's suggested price before any discounts, insurance coverage, or savings programs are applied. The retail price of Wegovy is $1349 [https://www.medicalnewstoday.com/articles/drugs-wegovy-cost]. This high list price often makes the medication seem out of reach for many, but it is important to understand that few patients actually pay this full amount. The final cost to a patient is influenced by several factors, including their specific treatment plan, the extent of their insurance coverage, and the particular pharmacy they choose to use.

Understanding the List Price vs. Actual Cost

The list price is essentially a benchmark. It is the price that pharmaceutical companies set for their drugs before negotiations with insurance companies, government programs, or pharmacy benefit managers. For patients, this means that the list price is rarely the true out-of-pocket cost. When we compare the list price of about $1,350 per month for both the weekly injection pen and the daily pill, it highlights the significant financial commitment involved before any savings are considered [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV]. This high initial cost underscores the importance of exploring all available savings options.

For instance, the retail price of Wegovy is $1349. This slight difference from the approximate $1,350 list price can be attributed to various market dynamics and slight rounding in reported figures. However, the core message remains: the sticker price is substantial. Patients should not be discouraged by this number alone but rather focus on what their personal cost will be after factoring in all potential reductions.

Factors Influencing the Final Price

Several variables can affect the final price a patient pays for Wegovy. Your treatment plan, for example, might involve different dosages or durations, which could subtly impact the total cost over time, although the monthly cost per pen or pill pack typically remains consistent. The pharmacy you use also plays a role. Different pharmacies may have varying markups or participate in different discount programs, leading to slight price differences for cash-paying customers or those with specific insurance plans.

Most significantly, insurance coverage dictates a large portion of the final cost. While some insurance plans may cover a substantial portion of the cost, others might offer limited or no coverage, especially when Wegovy is prescribed for weight loss rather than diabetes management. This distinction in coverage for weight loss versus diabetes is a critical point that many patients encounter. The landscape of drug pricing, manufacturer programs, and insurance coverage continues to shift, making it essential to stay informed before deciding whether Wegovy fits your budget. Understanding these components is the first step in navigating the financial aspects of Wegovy treatment.

In our analysis of drug pricing, we observe that the retail price of Wegovy stands at $1349. This figure, though high, serves as the starting point for any financial discussion regarding the medication. It is the price from which all discounts, coupons, and insurance benefits are subtracted. Therefore, while the list price might seem daunting, it is the maximum potential cost, and most individuals will find ways to reduce this amount. Our goal is to help patients understand how to bridge the gap between this list price and a more affordable out-of-pocket expense.

The financial journey with Wegovy begins with acknowledging its retail price. From there, patients can explore various avenues to reduce their financial burden. These avenues include, but are not limited to, insurance benefits, manufacturer savings programs, and prescription discount cards. Each of these components plays a vital role in determining the final cost, moving the patient's actual payment significantly lower than the initial $1349 retail price. We encourage patients to proactively discuss these options with their healthcare providers and pharmacists to gain a clear picture of their expected expenses.

How Much Does Wegovy Cost Without Insurance in 2026?

Without insurance, the cash-pay prices for Wegovy in 2026 show a significant reduction from the list price, especially through specific manufacturer programs. For the weekly injection pen, individuals can expect to pay approximately $199–$349 per month. The newer Wegovy pill, which was approved in late 2025, offers a slightly lower cash-pay range of $149–$299 monthly. These estimated prices are typically available through NovoNordisk’s NovoCare Pharmacy, highlighting the benefit of direct manufacturer programs for uninsured or self-pay patients [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV].

Cash-Pay Options for the Wegovy Injection Pen

For patients who do not have insurance or whose insurance plans do not cover weight-loss medications, the cash-pay price for the Wegovy injection pen in 2026 typically falls between $199 and $349 per month. This is a substantial drop from the list price of $1,350. This pricing structure is often made possible through direct-to-consumer programs offered by the manufacturer, Novo Nordisk. These programs are designed to make the medication more accessible to a broader range of patients, recognizing that insurance coverage for weight loss treatments can be inconsistent.

When considering these cash-pay options, it is important to remember that the price can still vary depending on the specific pharmacy and any additional discount programs they might offer. However, the figures provided by NovoNordisk’s NovoCare Pharmacy give a strong indication of the most competitive pricing available for those paying out of pocket. Patients should inquire directly with NovoCare Pharmacy or their local pharmacies about these cash prices to confirm their exact out-of-pocket expense.

Cash-Pay Options for the Newly Approved Wegovy Pill

The landscape for Wegovy pricing expanded with the approval of the new Wegovy pill in late 2025. This oral formulation offers another option for patients, and its cash-pay price without insurance is generally lower than the injection. Patients can expect to pay between $149 and $299 per month for the pill version. This difference in price between the injection and the pill might influence a patient's choice, alongside factors like convenience and personal preference.

The introduction of the pill form provides an alternative for individuals who may prefer not to use injections or who find the slightly lower monthly cost more manageable. Similar to the injection pen, these cash prices for the pill are typically found through manufacturer-backed programs like NovoNordisk’s NovoCare Pharmacy. It is essential for patients to compare the costs and benefits of both the injection and pill forms, especially when paying without insurance, to determine the most suitable and affordable treatment path. For more details, see Wegovy Cost & Coverage Information.

The Role of Manufacturer Programs

Manufacturer programs, such as NovoNordisk’s NovoCare Pharmacy, play a critical role in making Wegovy more affordable for cash-paying patients. These programs often bypass the complex insurance negotiation process and offer a more direct, reduced price. The shift in pricing over time, influenced by government rules, regulations, and these manufacturer initiatives, underscores the dynamic nature of drug costs. For instance, the fact that without insurance, cash-pay prices in 2026 typically range from about $199–$349 per month for the injection pen and $149–$299 for the pill, through NovoNordisk’s NovoCare Pharmacy, illustrates a significant effort to reduce financial barriers [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV].

These programs are particularly valuable for individuals who are uninsured, whose plans do not cover weight-loss medications, or who are trying to understand their true out-of-pocket options. When we analyze the cost landscape, it becomes clear that relying solely on the list price is misleading. Instead, patients must actively seek out and leverage these manufacturer programs to access Wegovy at a more manageable price point. Staying informed about these offerings is crucial for anyone considering Wegovy treatment without traditional insurance coverage.

What Are Wegovy Savings Programs and Coupons in 2026?

Wegovy savings programs and coupons in 2026 offer valuable opportunities to reduce the out-of-pocket cost of the medication. Patients may be able to save up to $55 per fill off the retail price of Wegovy through various programs. These savings can come from manufacturer-sponsored savings cards or from prescription discount websites that provide coupons. It is important to note that while these discount coupons can significantly lower the price, they generally cannot be combined with insurance copays or benefits, meaning patients must choose between using their insurance or a coupon for the greatest savings [https://www.medicalnewstoday.com/articles/drugs-wegovy-cost].

Manufacturer Savings Cards and Eligibility

Novo Nordisk, the maker of Wegovy, often provides savings cards or patient assistance programs designed to help reduce costs for eligible patients. While specific eligibility criteria can vary and are subject to change, these programs typically target commercially insured patients who still face high out-of-pocket expenses, as well as uninsured or underinsured individuals. The goal is to bridge the gap between the list price and what a patient can reasonably afford.

For example, you may be able to save up to $55 per fill off of the retail price [https://www.medicalnewstoday.com/articles/drugs-wegovy-cost]. This type of direct saving can make a noticeable difference in the monthly cost for many patients. To qualify, patients usually need a valid prescription for Wegovy and must meet certain income or insurance status requirements. It is always recommended to visit the official Wegovy website or contact their patient support line for the most up-to-date eligibility criteria and application process for these manufacturer programs.

Utilizing Prescription Discount Websites

Beyond manufacturer programs, several prescription discount websites offer coupons that can lower the cost of Wegovy. These websites aggregate discounts from various sources, providing patients with printable coupons or digital codes to present at the pharmacy. The discounted price offered through these coupons may sometimes be lower than what a patient would pay through their insurance, especially if their plan has a high deductible or limited coverage for weight-loss medications.

However, a key limitation of these coupons is that they cannot be used in conjunction with insurance copays or benefits. This means patients must decide whether to use their insurance or the discount coupon, depending on which offers the greater savings. It is advisable to compare the estimated cost with insurance versus the discounted price from a coupon before making a purchase. Websites like GoodRx, SingleCare, or the pharmacy's own discount programs are common places to find such coupons.

The Evolving Landscape of Savings

The availability and terms of Wegovy savings programs and coupons are not static. They can change over time due to shifts in government rules and regulations, updates to manufacturer programs, and evolving pharmacy practices. The approval of the new Wegovy pill in late 2025, for instance, adds another dimension to pricing and potential savings options. Staying informed about these changes is crucial for patients looking to manage their medication costs effectively.

We find that drug pricing, manufacturer programs, and insurance coverage continue to shift, making it worthwhile to stay informed before deciding whether Wegovy fits your budget [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV]. This dynamic environment means that what was true for savings last year might not be true today, or next year. Therefore, patients should regularly check for new programs, coupon updates, and changes in eligibility requirements. Consulting with a doctor, pharmacist, or insurance provider is the best way to determine the most current and applicable savings options for an individual's specific situation. This ongoing vigilance ensures that patients can leverage the best possible financial assistance for their Wegovy treatment.

How Does Insurance Coverage Affect Wegovy Cost?

Insurance coverage significantly impacts the cost of Wegovy, potentially reducing the monthly expense from hundreds of dollars to a much more manageable range. With insurance, the estimated monthly price for both the injection pen and the pill can range from $25 to $150, though this varies greatly depending on the specific plan and its coverage for weight-loss medications. While some of that is changing, insurance is rarely accepted when a medication is used for weight loss, meaning many patients will still pay out of pocket for Wegovy [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV]. The cost of prescription medications, such as Wegovy, is typically higher without insurance than with it.

The Role of Your Specific Insurance Plan

The level of coverage for Wegovy depends entirely on your specific health insurance plan. Some plans may include comprehensive coverage for GLP-1 medications, especially if they are prescribed for conditions like type 2 diabetes. However, when Wegovy is prescribed primarily for weight loss, many insurance plans have historically been reluctant to cover it. This is slowly changing, but it remains a significant hurdle for many patients. Even if a plan offers some coverage, patients might still face high deductibles, co-pays, or co-insurance amounts.

We observe that with insurance, the estimated monthly price is $25–$150 for both the injection pen and the pill, but this varies by plan and coverage [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV]. This wide range indicates that even with insurance, the financial burden can differ significantly from person to person. It is crucial to contact your insurance provider directly to understand the specifics of your plan's coverage for Wegovy, including any prior authorization requirements or formulary restrictions. For more details, see Wegovy Cost Without Insurance in 2026.

Prior Authorization Challenges

One common challenge with insurance coverage for GLP-1 medications like Wegovy is the requirement for prior authorization. This means your doctor must submit documentation to your insurance company explaining why Wegovy is medically necessary for you. This process can be time-consuming and sometimes results in denials, even if your doctor believes the medication is essential. Prior authorization challenges are a significant hurdle in accessing GLP-1 medications.

"Navigating GLP-1 Medications: Prior Authorization Challenges and Solutions" provides insight into the complexities of this process [https://www.pharmacytimes.com/view/navigating-glp-1-medications-prior-authorization-challenges-and-solutions]. Providers often need to demonstrate that a patient has tried and failed other treatments, or that specific health criteria are met, before approval is granted. Simplifying GLP-1 prior authorization is an ongoing effort within the healthcare system, as noted by CoverMyMeds [https://www.covermymeds.health/articles/provider-insights/simplify-glp-1-prior-authorization-with-covermymeds]. Patients should work closely with their healthcare provider's office to ensure all necessary paperwork is submitted accurately and promptly.

The Cost Difference: Insured vs. Uninsured

The difference in cost between having insurance coverage and paying without it can be dramatic. As noted, the cost of prescription medications, such as Wegovy, is typically higher without insurance than with insurance [https://www.medicalnewstoday.com/articles/drugs-wegovy-cost]. While the list price of Wegovy is around $1,350 per month, an insured patient might pay as little as $25–$150 monthly, depending on their plan. In contrast, an uninsured patient, even with manufacturer programs, might still pay $149–$349 per month.

This highlights the critical role of insurance in making high-cost medications accessible. For those without adequate insurance coverage for weight loss, exploring manufacturer savings programs and prescription discount coupons becomes even more vital. We encourage all patients to talk with their doctor, pharmacist, or insurance provider to get a clear understanding of what the cost of Wegovy will be for them. This proactive approach can help patients prepare for the financial commitment and explore all available options to reduce their out-of-pocket expenses for this important medication.

What Important Safety Information Should I Know About Wegovy?

It is critical to be aware that Wegovy may cause serious side effects, including possible thyroid tumors, which could include cancer. Patients should immediately tell their healthcare provider if they notice a lump or swelling in their neck, experience hoarseness, have trouble swallowing, or feel shortness of breath, as these could be symptoms of thyroid cancer. Studies in rodents have shown that Wegovy and similar medicines caused thyroid tumors, including thyroid cancer, though it is not known if this risk extends to humans or causes a specific type of thyroid cancer called medullary thyroid carcinoma (MTC) [https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html].

Contraindications and Warnings

There are specific situations where Wegovy should not be used. You must not use Wegovy if you or any of your family members have ever had medullary thyroid carcinoma (MTC), or if you have an endocrine system condition known as Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Additionally, Wegovy is contraindicated if you have had a serious allergic reaction to semaglutide or any other ingredients in the Wegovy injection or tablets. Symptoms of a serious allergic reaction can include swelling of your face, lips, tongue, or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and a very rapid heartbeat [https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html].

Before starting Wegovy, it is essential to discuss your complete medical history with your healthcare provider. This includes any past or current problems with your pancreas or kidneys, or if you have type 2 diabetes with a history of diabetic retinopathy. If you are scheduled for surgery or other procedures requiring anesthesia or deep sedation, inform your provider about your Wegovy use.

Pregnancy, Breastfeeding, and Other Medications

For women who are pregnant or planning to become pregnant, Wegovy may harm an unborn baby. It is recommended to stop using Wegovy at least 2 months before you plan to conceive. For breastfeeding mothers, breastfeeding is not recommended during treatment with Wegovy tablets. It is currently unknown whether the active ingredient in Wegovy injections passes into breast milk [https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html].

It is also crucial to inform your healthcare provider about all medicines you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements. Wegovy can interact with other medications, affecting how they work or how Wegovy itself works. Specifically, if you are taking other medicines for diabetes, such as sulfonylureas or insulin, your provider will need to monitor you closely. Wegovy slows stomach emptying, which can impact medicines that need to pass through the stomach quickly.

Other Possible Serious Side Effects

Beyond the risk of thyroid tumors, Wegovy can cause other serious side effects. One such side effect is inflammation of your pancreas, known as pancreatitis. If you experience severe pain in your stomach area (abdomen) that does not go away, with or without nausea or vomiting, you should stop using Wegovy and call your healthcare provider right away. This pain can sometimes spread from your abdomen to your back [https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html].

Gallbladder problems, including gallstones, are another potential side effect. Some gallstones may require surgery. You should contact your healthcare provider if you have symptoms such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools. Understanding these potential risks and knowing when to seek medical attention is a vital part of safe Wegovy treatment. "Wegovy may cause serious side effects, including possible thyroid tumors, including cancer," states the official Wegovy safety information. "Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer." This direct warning from the manufacturer underscores the importance of vigilance while on this medication [https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html].

Are There New Wegovy Pricing Options in 2026?

Yes, there are new Wegovy pricing options emerging in 2026, driven by market changes and manufacturer initiatives. According to an April 2, 2026 news report from Powers Health, the maker of Wegovy has launched lower-cost subscription plans, signaling a shift in how the medication is made available to consumers [https://www.powershealth.org/about-us/newsroom/health-library/2026/04/02/wegovy-maker-launches-lower-cost-subscription-plans]. Furthermore, the approval of the new Wegovy pill in late 2025 introduced an additional formulation with its own pricing structure, offering more choices for patients. The overall landscape of drug pricing, manufacturer programs, and insurance coverage continues to evolve, making it essential for patients to stay informed about the latest developments. For more details, see Wegovy cost 2026: Coupons, savings, and more.

Introduction of Subscription Plans

The launch of lower-cost subscription plans by the maker of Wegovy represents a significant change in how patients can access and pay for the medication. This model, reported on April 2, 2026, by Powers Health, could provide a more predictable and potentially more affordable payment structure for many individuals [https://www.powershealth.org/about-us/newsroom/health-library/2026/04/02/wegovy-maker-launches-lower-cost-subscription-plans]. Subscription plans typically involve a recurring monthly fee that covers the cost of the medication, often bypassing the complexities of traditional insurance claims or offering a fixed price for uninsured patients.

These plans could be particularly beneficial for patients who face high deductibles, limited insurance coverage for weight-loss medications, or those who prefer a straightforward, predictable monthly expense. The details of these subscription plans, including eligibility requirements and specific pricing, would need to be obtained directly from the manufacturer or through authorized pharmacies. This move indicates a proactive effort by the manufacturer to address the cost barriers that have historically limited access to GLP-1 medications.

The Impact of the Wegovy Pill

The approval of the new Wegovy pill in late 2025 expanded the treatment options available, and with it, introduced new pricing considerations. While the weekly injection pen remains an option, the daily pill provides an alternative for patients who may prefer an oral medication or find its slightly different cost structure more appealing. Without insurance, the Wegovy pill may cost $149–$299 monthly, which is generally lower than the injection pen's cash price of $199–$349 per month [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV].

This new formulation not only offers a choice in administration method but also adds another layer to the pricing landscape. Patients can now compare the costs and benefits of both the injection and pill forms, considering factors like convenience, adherence, and financial implications. The availability of the pill could also potentially influence insurance coverage decisions and the structure of future savings programs.

The Dynamic Nature of Drug Pricing

The introduction of subscription plans and the new pill formulation are part of a broader, continuously shifting environment for drug pricing. Government rules and regulations, ongoing manufacturer programs, and evolving insurance coverage policies all contribute to this dynamic landscape. This means that what patients pay for Wegovy can change over time, making it crucial to stay informed. We recognize that drug pricing, manufacturer programs, and insurance coverage continue to shift, making it worthwhile to stay informed before deciding whether Wegovy fits your budget [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV].

For instance, the list price for both the injection pen and the pill remains about $1,350 per month, but the actual out-of-pocket costs are often much lower due to these evolving programs. Patients should actively monitor announcements from the manufacturer, consult with their healthcare providers, and regularly check their insurance plan details to ensure they are leveraging the most current and beneficial pricing options. This proactive approach is key to navigating the updated cost landscape of Wegovy in 2026 and beyond.

Frequently Asked Questions

Can I use a Wegovy savings card if I have insurance?

Yes, you may be able to use a Wegovy savings card if you have commercial insurance. These cards are often designed to help commercially insured patients reduce their out-of-pocket costs, such as co-pays or deductibles. However, it is important to understand that prescription discount coupons found on websites generally cannot be combined with insurance benefits; you must choose which one provides the most savings. Always check the specific terms and conditions of any savings card or coupon, as eligibility criteria can vary.

What is the difference in cost between the Wegovy injection and the pill?

The cash-pay cost without insurance for the Wegovy injection pen in 2026 typically ranges from $199–$349 per month through NovoNordisk’s NovoCare Pharmacy. In contrast, the newer Wegovy pill, approved in late 2025, may cost $149–$299 monthly without insurance through the same program [https://www.noom.com/blog/weight-management/wegovy-cost-without-insurance/?srsltid=AfmBOoqGPhQKiQvaAqm_j3HOWpG1WtGmFDc1JklYiYmF5dkbtRd5J5kV]. This indicates that the pill form can be slightly more affordable for those paying out of pocket. With insurance, the estimated monthly price for both forms ranges from $25–$150, varying by plan and coverage.

Who should not use Wegovy?

You should not use Wegovy if you or any of your family have ever had medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Additionally, Wegovy is not recommended if you have had a serious allergic reaction to semaglutide or any other ingredients in the medication [https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html]. It is also not recommended for pregnant or breastfeeding individuals, and those with a history of pancreatitis or severe kidney problems should discuss risks with their doctor.

Where can I find discount coupons for Wegovy?

You can find discount coupons for Wegovy through several avenues. The official Wegovy website or Novo Nordisk's NovoCare Pharmacy often provides manufacturer-sponsored savings programs. Additionally, prescription discount websites, such as GoodRx or SingleCare, may offer coupons that can reduce the cost. Remember that while these coupons can save up to $55 per fill off the retail price, they typically cannot be used with insurance copays or benefits [https://www.medicalnewstoday.com/articles/drugs-wegovy-cost].

Does Wegovy slow stomach emptying?

Yes, Wegovy is known to slow stomach emptying. This effect can impact how other medicines work, especially those that need to pass through the stomach quickly. It is crucial to tell your healthcare provider about all medicines you are taking, including prescription and over-the-counter drugs, vitamins, and herbal supplements, so they can assess any potential interactions [https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html]. This slowed gastric emptying is part of how GLP-1 medications help promote feelings of fullness and reduce appetite.